Chapter/Section Purchase

1 Study Coverage
1.1 Mesalamine Product Introduction
1.2 Market by Type
1.2.1 Global Mesalamine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ? 97%
1.2.3 Purity ? 98%
1.2.4 Purity ? 99%
1.3 Market by Application
1.3.1 Global Mesalamine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Mesalazine Tablets
1.3.3 Mesalazine Capsules
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mesalamine Sales Estimates and Forecasts 2017-2028
2.2 Global Mesalamine Revenue Estimates and Forecasts 2017-2028
2.3 Global Mesalamine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Mesalamine Sales by Region
2.4.1 Global Mesalamine Sales by Region (2017-2022)
2.4.2 Global Sales Mesalamine by Region (2023-2028)
2.5 Global Mesalamine Revenue by Region
2.5.1 Global Mesalamine Revenue by Region (2017-2022)
2.5.2 Global Mesalamine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Mesalamine Sales by Manufacturers
3.1.1 Global Top Mesalamine Manufacturers by Sales (2017-2022)
3.1.2 Global Mesalamine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mesalamine in 2021
3.2 Global Mesalamine Revenue by Manufacturers
3.2.1 Global Mesalamine Revenue by Manufacturers (2017-2022)
3.2.2 Global Mesalamine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Mesalamine Revenue in 2021
3.3 Global Mesalamine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Mesalamine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Mesalamine Sales by Type
4.1.1 Global Mesalamine Historical Sales by Type (2017-2022)
4.1.2 Global Mesalamine Forecasted Sales by Type (2023-2028)
4.1.3 Global Mesalamine Sales Market Share by Type (2017-2028)
4.2 Global Mesalamine Revenue by Type
4.2.1 Global Mesalamine Historical Revenue by Type (2017-2022)
4.2.2 Global Mesalamine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Mesalamine Revenue Market Share by Type (2017-2028)
4.3 Global Mesalamine Price by Type
4.3.1 Global Mesalamine Price by Type (2017-2022)
4.3.2 Global Mesalamine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Mesalamine Sales by Application
5.1.1 Global Mesalamine Historical Sales by Application (2017-2022)
5.1.2 Global Mesalamine Forecasted Sales by Application (2023-2028)
5.1.3 Global Mesalamine Sales Market Share by Application (2017-2028)
5.2 Global Mesalamine Revenue by Application
5.2.1 Global Mesalamine Historical Revenue by Application (2017-2022)
5.2.2 Global Mesalamine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Mesalamine Revenue Market Share by Application (2017-2028)
5.3 Global Mesalamine Price by Application
5.3.1 Global Mesalamine Price by Application (2017-2022)
5.3.2 Global Mesalamine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Mesalamine Market Size by Type
6.1.1 North America Mesalamine Sales by Type (2017-2028)
6.1.2 North America Mesalamine Revenue by Type (2017-2028)
6.2 North America Mesalamine Market Size by Application
6.2.1 North America Mesalamine Sales by Application (2017-2028)
6.2.2 North America Mesalamine Revenue by Application (2017-2028)
6.3 North America Mesalamine Market Size by Country
6.3.1 North America Mesalamine Sales by Country (2017-2028)
6.3.2 North America Mesalamine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Mesalamine Market Size by Type
7.1.1 Europe Mesalamine Sales by Type (2017-2028)
7.1.2 Europe Mesalamine Revenue by Type (2017-2028)
7.2 Europe Mesalamine Market Size by Application
7.2.1 Europe Mesalamine Sales by Application (2017-2028)
7.2.2 Europe Mesalamine Revenue by Application (2017-2028)
7.3 Europe Mesalamine Market Size by Country
7.3.1 Europe Mesalamine Sales by Country (2017-2028)
7.3.2 Europe Mesalamine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Mesalamine Market Size by Type
8.1.1 Asia Pacific Mesalamine Sales by Type (2017-2028)
8.1.2 Asia Pacific Mesalamine Revenue by Type (2017-2028)
8.2 Asia Pacific Mesalamine Market Size by Application
8.2.1 Asia Pacific Mesalamine Sales by Application (2017-2028)
8.2.2 Asia Pacific Mesalamine Revenue by Application (2017-2028)
8.3 Asia Pacific Mesalamine Market Size by Region
8.3.1 Asia Pacific Mesalamine Sales by Region (2017-2028)
8.3.2 Asia Pacific Mesalamine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Mesalamine Market Size by Type
9.1.1 Latin America Mesalamine Sales by Type (2017-2028)
9.1.2 Latin America Mesalamine Revenue by Type (2017-2028)
9.2 Latin America Mesalamine Market Size by Application
9.2.1 Latin America Mesalamine Sales by Application (2017-2028)
9.2.2 Latin America Mesalamine Revenue by Application (2017-2028)
9.3 Latin America Mesalamine Market Size by Country
9.3.1 Latin America Mesalamine Sales by Country (2017-2028)
9.3.2 Latin America Mesalamine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Mesalamine Market Size by Type
10.1.1 Middle East and Africa Mesalamine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Mesalamine Revenue by Type (2017-2028)
10.2 Middle East and Africa Mesalamine Market Size by Application
10.2.1 Middle East and Africa Mesalamine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Mesalamine Revenue by Application (2017-2028)
10.3 Middle East and Africa Mesalamine Market Size by Country
10.3.1 Middle East and Africa Mesalamine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Mesalamine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Syntese A/S
11.1.1 Syntese A/S Corporation Information
11.1.2 Syntese A/S Overview
11.1.3 Syntese A/S Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Syntese A/S Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Syntese A/S Recent Developments
11.2 Divis Laboratories
11.2.1 Divis Laboratories Corporation Information
11.2.2 Divis Laboratories Overview
11.2.3 Divis Laboratories Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Divis Laboratories Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Divis Laboratories Recent Developments
11.3 Cambrex Corporation
11.3.1 Cambrex Corporation Corporation Information
11.3.2 Cambrex Corporation Overview
11.3.3 Cambrex Corporation Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cambrex Corporation Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cambrex Corporation Recent Developments
11.4 Ipca Laboratories
11.4.1 Ipca Laboratories Corporation Information
11.4.2 Ipca Laboratories Overview
11.4.3 Ipca Laboratories Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ipca Laboratories Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ipca Laboratories Recent Developments
11.5 Hangzhou Brother
11.5.1 Hangzhou Brother Corporation Information
11.5.2 Hangzhou Brother Overview
11.5.3 Hangzhou Brother Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Hangzhou Brother Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hangzhou Brother Recent Developments
11.6 PharmaZell
11.6.1 PharmaZell Corporation Information
11.6.2 PharmaZell Overview
11.6.3 PharmaZell Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 PharmaZell Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 PharmaZell Recent Developments
11.7 Lianyungang Fengheng Biopharm
11.7.1 Lianyungang Fengheng Biopharm Corporation Information
11.7.2 Lianyungang Fengheng Biopharm Overview
11.7.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Lianyungang Fengheng Biopharm Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lianyungang Fengheng Biopharm Recent Developments
11.8 Lasa Loboratory
11.8.1 Lasa Loboratory Corporation Information
11.8.2 Lasa Loboratory Overview
11.8.3 Lasa Loboratory Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lasa Loboratory Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lasa Loboratory Recent Developments
11.9 Erregierre SpA
11.9.1 Erregierre SpA Corporation Information
11.9.2 Erregierre SpA Overview
11.9.3 Erregierre SpA Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Erregierre SpA Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Erregierre SpA Recent Developments
11.10 Corden Pharma Bergamo
11.10.1 Corden Pharma Bergamo Corporation Information
11.10.2 Corden Pharma Bergamo Overview
11.10.3 Corden Pharma Bergamo Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Corden Pharma Bergamo Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Corden Pharma Bergamo Recent Developments
11.11 CTX Lifescience
11.11.1 CTX Lifescience Corporation Information
11.11.2 CTX Lifescience Overview
11.11.3 CTX Lifescience Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 CTX Lifescience Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CTX Lifescience Recent Developments
11.12 Ishita Active Pharma Ingredients
11.12.1 Ishita Active Pharma Ingredients Corporation Information
11.12.2 Ishita Active Pharma Ingredients Overview
11.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Ishita Active Pharma Ingredients Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Ishita Active Pharma Ingredients Recent Developments
11.13 YC Biotech (Jiangsu)
11.13.1 YC Biotech (Jiangsu) Corporation Information
11.13.2 YC Biotech (Jiangsu) Overview
11.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 YC Biotech (Jiangsu) Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 YC Biotech (Jiangsu) Recent Developments
11.14 Xinxiang Tianfeng Fine Chemical
11.14.1 Xinxiang Tianfeng Fine Chemical Corporation Information
11.14.2 Xinxiang Tianfeng Fine Chemical Overview
11.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Xinxiang Tianfeng Fine Chemical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Mesalamine Industry Chain Analysis
12.2 Mesalamine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mesalamine Production Mode & Process
12.4 Mesalamine Sales and Marketing
12.4.1 Mesalamine Sales Channels
12.4.2 Mesalamine Distributors
12.5 Mesalamine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Mesalamine Industry Trends
13.2 Mesalamine Market Drivers
13.3 Mesalamine Market Challenges
13.4 Mesalamine Market Restraints
14 Key Findings in The Global Mesalamine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer